Grants & Training
Information about grants and other funding opportunities for cancer research, the NCI grants process, and funding for training.
Information about grants and other funding opportunities for cancer research, the NCI grants process, and funding for training.
People diagnosed with CRC before 50 years of age comprise a population with its own set of circumstances and needs.
Cosponsor the Sickle Cell Disease Comprehensive Care Act
Contact Your Legislators to Address Drug Shortages in Hematology and Oncology Care
Circulating tumor DNA (ctDNA) holds promise as a biomarker for predicting clinical responses to therapy in solid tumors, and multiple ctDNA assays are in development.…
If approved, zenocutuzumab would be the first targeted therapy for neuregulin 1 fusion-positive lung and pancreatic cancers.
Cancer is an international interdisciplinary journal publishing articles on the latest clinical cancer research findings, spanning the breadth of oncology disciplines.
Treatment with loncastuximab tesirine yielded high response rates in patients with relapsed or refractory marginal zone lymphoma.
Published: August 16, 2023Medically Reviewed By: Pamela J. DiPiro, MDBreast cancer is one of the most common forms of cancer and affects almost 300,000 women…
The time is now. Use your VOICE to change the future of cancer as we know it.
Prefibrotic myelofibrosis is the focus of “SOHO State of the Art Updates and Next Questions.”